Comprehensive Study Notes on Typical Antipsychotics

Overview of Typical Antipsychotics

  • Classification: Antipsychotics are categorized into two primary types: typical and atypical.

  • Terminology: Typical antipsychotics are also referred to as first-generation antipsychotics because they are the older class of these medications.

  • Indications: Typical antipsychotics are used for the following clinical purposes:

    • Treatment of acute psychosis.

    • Management of psychotic disorders, specifically schizophrenia.

  • Clinical Efficacy in Schizophrenia:

    • Positive Symptoms: Typical antipsychotics are effective in treating positive symptoms (e.g., hallucinations, delusions).

    • Negative Symptoms: They are not effective in treating the negative symptoms of schizophrenia (e.g., social withdrawal, lack of motivation).

Mechanism of Action

  • The Dopamine Hypothesis: Psychosis and psychotic disorders are believed to be caused by an increased amount of the neurotransmitter dopamine within the brain.

  • Dopamine Receptors: There are two main types of dopamine receptors in the brain:

    • Type One (D1D_1).

    • Type Two (D2D_2).

    • Both types include various subtypes.

  • Pharmacodynamics: Typical antipsychotics work by antagonizing postsynaptic dopamine two (D2D_2) receptor sites.

    • This mechanism blocks dopamine transmission.

    • It decreases the total amount of dopamine activity in the brain, thereby eliminating or reducing the symptoms of psychosis.

Examples and Administration Routes

  • Specific Medications: Representative examples of typical antipsychotics include:

    • Haloperidol

    • Chlorpromazine

    • Thioridazine

    • Flupentazole

  • Routes of Administration:

    • Oral: Typical antipsychotics can be taken by mouth.

    • Intramuscular (IM) Injection: Some forms can be administered as an injection.

  • Depot Antipsychotics:

    • Definition: A depot is a long-acting, sustained-release formulation of an antipsychotic given as an intramuscular injection.

    • Frequency: These are typically administered every 22 or 44 weeks (fortnightly or monthly).

    • Indications for Depot Use:

    • Prescribed for individuals on a treatment order to ensure they receive their medication.

    • Chosen by patients who prefer not to take daily oral medication to improve adherence.

  • Pharmacokinetic and Pharmacodynamic Considerations for Depots:

    • Absorption, distribution, metabolism, and elimination (ADMEADME) are significantly slower compared to the oral route.

    • Clinical Implication: Adverse effects will take a longer time to appear and a correspondingly longer time to resolve once the medication is stopped.

Ethical and Clinical Nursing Considerations

  • Medication Administration Ethics: Nurses must recognize that IM injections are invasive and potentially traumatic, especially when administered without consent under a treatment order.

  • Standards of Care:

    • Uphold dignity, respect, and privacy at all times.

    • Prioritize clear communication and patient education.

Serious Adverse Effects: Extrapyramidal Effects

  • Cause: Typical antipsychotics have additional effects at the synapse that result in movement disorders, collectively known as extrapyramidal effects (EPSEsEPSEs).

  • Types of Extrapyramidal Effects:

    • Tardive Dyskinesia: Characterized by involuntary muscle movements, such as lip smacking or rolling of the tongue.

    • Akathisia: Characterized by internal restlessness and physical agitation.

    • Acute Dystonias: Sudden and often painful muscle spasms of the head, neck, and torso.

    • Parkinsonism: The presentation of symptoms similar to Parkinson's disease (e.g., tremors, rigidity).

  • Impact on Treatment: These effects significantly impair quality of life and are poorly tolerated, often leading to non-adherence (patients choosing to stop medication against medical advice).

Life-Threatening Complication: Neuroleptic Malignant Syndrome (NMS)

  • Nature: NMS is a life-threatening medical emergency if not identified and treated promptly.

  • Symptom Clusters for Identification: To assist in learning, the signs and symptoms are categorized into four areas:

    1. Hyperthermia (High fever).

    2. Mental Status Changes.

    3. Muscle Rigidity.

    4. Autonomic Instability.

  • Nursing Management of NMS:

    • Frequent assessment for signs and symptoms.

    • Escalation and initiation of immediate care upon detection.

    • Cessation of the antipsychotic medication in consultation with a medical officer.

    • Provision of supportive therapy.

    • Close monitoring of the patient.

    • Arrangement of transfer to an Intensive Care Unit (ICUICU) if the patient is severely unwell.

Other Adverse Effects

  • Less Severe Side Effects:

    • Sedation.

    • Photosensitivity.

    • Weight gain.

    • Anticholinergic effects (e.g., dry mouth, blurred vision).

Comprehensive Patient Education

  • Safety Education: Patients must be taught the signs and symptoms of extrapyramidal effects and NMS so they can seek medical help early to prevent deterioration.

  • Medication Adherence Instructions:

    • Take medication exactly as prescribed.

    • Seek medical advice if side effects become intolerable or concerning.

    • Warning: Do not suddenly stop taking the medication.

    • Continue the medication regimen even if the symptoms of psychosis have improved and the person feels better.